FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to medicine, in particular, to application of secretion-stimulating peptide GHRP-6, which is repeatedly introduced in composition of pharmaceutical composition, which prevents and removes deposits of pathological fibrous material in parenchymatous tissues of internal organs, such as liver, lungs, esophagus, small intestine, kidneys, blood vessels, joints, and other system forms of skin fibrosis of any etiopathogenesis. In addition, said peptide prevents and removes deposits of amyloid and hyaline material in any their forms and types of tissues, including, in brain, cerebellum, blood vessels, liver, intestine, kidneys, pancreas, joints and skin. Thus, it corrects cellular, tissue and organ dysfunctions, caused by said deposits. Peptide, in accordance with claimed invention, is applied by infiltration or locally, contributing to prevention and removal of keloids and hypertrophic scars in skin, resulting from burns and other skin trauma.
EFFECT: group of inventions ensures fast reduction of excessive amount of collagen material and extracellular matrix, removal of pathological deposits of fibrous material in parenchymatous internal tissues.
26 cl, 7 ex, 19 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS AND METHODS OF TREATING NEUROLOGICAL DISTURBANCES | 2005 |
|
RU2387453C2 |
PEPTIDE AND METHOD OF TREATMENT OF ALZHEIMER'S DISEASE | 2018 |
|
RU2679080C1 |
PEPTIDE AND METHOD OF TREATMENT OF ALZHEIMER'S DISEASE | 2018 |
|
RU2679059C1 |
ADVANCED COMPOUND FOR THE TREATMENT OF HEART FAILURE | 2018 |
|
RU2794975C2 |
HUMANISED ANTIBODIES TO β-AMYLOID PEPTIDE | 2008 |
|
RU2475500C2 |
ADENO-ASSOCIATED VIRUS VECTOR FOR ALZHEIMER'S DISEASE TREATMENT, ITS APPLICATION FOR RECEPTION OF THERAPEUTIC AGENTS, AND ALSO METHOD OF ALZHEIMER'S DISEASE TREATMENT BY MEANS OF GIVEN VECTOR | 2004 |
|
RU2335542C2 |
ACTIVE IMMUNISATION FOR CREATING SOLUBLE A-BETA ANTIBODIES | 2004 |
|
RU2390350C2 |
TREATMENT OF HEART FAILURE IN HUMANS | 2020 |
|
RU2811365C2 |
HUMANISED ANTIBODY | 2008 |
|
RU2538709C2 |
ANTI-AMYLOID BETA (A BETA) 1-42 MONOCLONAL ANTIBODIES POSSESSING THERAPEUTIC PROPERTIES | 2006 |
|
RU2551782C2 |
Authors
Dates
2012-11-10—Published
2007-02-23—Filed